Furthermore, lymphoid and myeloid neoplasms associated respectively with t(9;12)(p24;p13); ETV6-JAK2 and with t(9;22)(p24;q11????2); BCR-JAK2 should be documented carefully in order to define their features more clearly and assess whether they can be recognized as entities.    ///    ETV6-JAK2 and with t(9;22)(p24;q11??2). 